Kringle Pharma has an EPS of $-68.33. In 2021, the company made an earnings per share (EPS) of $-72.51. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2022 | -$68.33 | -5.76% |
2021 | -$72.51 | -32.04% |
2020 | -$106.70 | - |